Cypress Asset Management Inc Novartis Ag Transaction History

Cypress Asset Management Inc

$357 Million
Q1 2024

A detailed history of Cypress Asset Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Cypress Asset Management Inc holds 8,146 shares of NVS stock, worth $801,973. This represents 0.22% of its overall portfolio holdings.

Number of Shares

8,146

Previous 8,246 1.21%

Holding current value

$801,973

Previous $832,000 5.41%

% of portfolio

0.22%

Previous 0.25%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 11, 2024	SELL	$95.27 - $108.47 $9,527 - $10,847	-100 Reduced 1.21%	8,146 $787,000
Q4 2023 Feb 09, 2024	BUY	$92.27 - $101.54 $10,887 - $11,981	118 Added 1.45%	8,246 $832,000
Q3 2023 Feb 09, 2024	BUY	$94.73 - $105.13 $16,767 - $18,608	177 Added 2.15%	8,423 $857,000
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $13,878 - $15,736	-150 Reduced 1.81%	8,128 $820,000
Q1 2023 May 25, 2023	SELL	$80.03 - $92.81 $8,403 - $9,745	-105 Reduced 1.25%	8,278 $761,000
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $26,571 - $30,937	-330 Reduced 3.79%	8,383 $709,000
Q1 2022 Jun 06, 2022	SELL	$80.11 - $90.62 $152,209 - $172,178	-1,900 Reduced 17.9%	8,713 $765,000
Q4 2021 Jan 31, 2022	SELL	$79.7 - $88.13 $16,418 - $18,154	-206 Reduced 1.9%	10,613 $928,000
Q3 2021 Oct 18, 2021	SELL	$81.78 - $95.14 $13,493 - $15,698	-165 Reduced 1.5%	10,819 $885,000
Q2 2021 Aug 06, 2021	SELL	$85.24 - $94.15 $126,240 - $139,436	-1,481 Reduced 11.88%	10,984 $1 Million
Q1 2021 Apr 22, 2021	SELL	$83.5 - $98.47 $128,172 - $151,151	-1,535 Reduced 10.96%	12,465 $1.07 Million
Q4 2020 Feb 10, 2021	SELL	$78.07 - $94.43 $7,806 - $9,443	-100 Reduced 0.71%	14,000 $1.32 Million
Q3 2020 Oct 26, 2020	SELL	$82.14 - $91.0 $54,623 - $60,515	-665 Reduced 4.5%	14,100 $1.23 Million
Q2 2020 Jul 28, 2020	SELL	$80.93 - $91.1 $4,855 - $5,466	-60 Reduced 0.4%	14,765 $1.29 Million
Q1 2020 May 07, 2020	BUY	$70.67 - $99.01 $15,194 - $21,287	215 Added 1.47%	14,825 $1.22 Million
Q4 2019 Feb 06, 2020	SELL	$84.35 - $95.37 $50,610 - $57,222	-600 Reduced 3.94%	14,610 $1.38 Million
Q3 2019 Oct 21, 2019	SELL	$85.54 - $94.26 $53,462 - $58,912	-625 Reduced 3.95%	15,210 $1.32 Million
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $9,425 - $11,600	125 Added 0.8%	15,835 $1.45 Million
Q1 2019 Apr 29, 2019	SELL	$75.32 - $86.15 $16,947 - $19,383	-225 Reduced 1.41%	15,710 $1.51 Million
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $19,667 - $21,899	-267 Reduced 1.65%	15,935 $1.37 Million
Q3 2018 Oct 19, 2018	SELL	$66.94 - $77.43 $6,694 - $7,743	-100 Reduced 0.61%	16,202 $1.4 Million
Q2 2018 Jul 27, 2018	SELL	$64.91 - $73.36 $55,173 - $62,356	-850 Reduced 4.96%	16,302 $1.23 Million
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $238,058 - $284,595	-3,382 Reduced 16.47%	17,152 $1.39 Million
Q4 2017 Jan 31, 2018	SELL	$72.33 - $77.64 $53,524 - $57,453	-740 Reduced 3.48%	20,534 $1.72 Million
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $1.58 Million - $1.64 Million	21,274	21,274 $1.83 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Asset Management Inc with notifications on news.

Account

Cypress Asset Management Inc Novartis Ag Transaction History